心脏丝氨酸蛋白酶及血管内皮因子在妊娠期高血压疾病中的表达及预测价值
[Abstract]:Objective: to detect vascular endothelial growth factor (vascular endothelial growth factor,VEGF (corin),) and placental growth factor (placenta growth factor, (placenta growth factor,) in serum of pregnant women during different pregnancy. The levels of PLGF) and soluble vascular endothelial growth factor receptor 1 (soluble vascular endothelial growth factor receptor 1, sFlt 1) were measured in patients with hypertensive disorder complicating pregnancy (hypertensive disorders complicating pregnancy,HDCP) and normal pregnant women. The diagnostic value of the above factors in predicting the occurrence of HDCP in early and middle trimester of pregnancy was also discussed. Methods: single-child pregnant women were selected from December 2015 to September 2016 in the outpatient department and in-patient department of the second Hospital of Lanzhou University. The levels of above factors in the serum of pregnant women in early, middle and third trimester of pregnancy were studied on the basis of the outcome of pregnancy. They were divided into HDCP group and normal pregnancy control group. Among them, 24 serum samples of HDCP patients were selected as the study group, and 24 healthy pregnant women were selected as the normal control group during the same period of gestation, and 24 serum samples of the pregnant women were selected as the study group in the first trimester of pregnancy. 55 serum samples of HDCP patients in the second trimester of gestation (16 weeks of gestation) were selected as the study group, and 55 healthy pregnant women in the same period were selected as the normal control group. Serum samples from 23 patients with HDCP (after 28 weeks of gestation) were selected as the study group, and 23 serum samples from healthy pregnant women at the same period were selected as the normal control group. The levels of corin,VEGF,PLGF,sFlt-1 in serum of each group were measured by ELISA method, and the differences of the above factors between groups were analyzed by statistical method. Logistic regression and ROC curve were used to evaluate the diagnostic value of single and combined detection of each factor in the early and middle trimester of pregnancy in predicting the occurrence of HDCP. Results: 1. In the first trimester of pregnancy, the levels of serum corin,VEGF and PLGF in HDCP group were significantly lower than those in control group (P 0.05). The level of serum sFlt-1 and the ratio of sFlt-1/PLGF were significantly higher in the two groups than those in the control group (P 0.05.2). In the second trimester of gestation, the level of serum VEGF,PLGF in HDCP group was significantly lower than that in control group (P 0.05). The levels of serum corin,sFlt-1 and the ratio of sFlt-1/PLGF were significantly higher in the two groups than those in the control group (P0.05.3. 3.) In the third trimester of gestation, the level of serum VEGF,PLGF in HDCP group was lower than that in control group, and there was significant difference between the two groups (P 0.05). The levels of serum corin,sFlt-1 and the ratio of sFlt-1/PLGF were significantly higher in the two groups than those in the control group (P 0.05.4). Logistic regression and ROC curve were used to evaluate the ratio of serum corin,VEGF,PLGF,sFlt-1 and sFlt-1/PLGF in pregnant women in the early and middle trimester of pregnancy. All serum factors had predictive value for the occurrence of HDCP. In the first trimester of pregnancy, the area under the AUC of the combined prediction probability PRE was 0.851, and the maximum Joden index was 0.625. The corresponding sensitivity and specificity were 83.3% and 79.2%, respectively. It was obviously higher than the prediction value of the single detection index and the sFlt-1/PLGF ratio. In the second trimester of pregnancy, the area under the AUC of the combined prediction probability PRE was 0.927, the largest Yodden index was 0.691, the corresponding sensitivity and specificity were 87.3% and 82.8%, respectively, and the relative sensitivity and specificity were 87.3% and 82.8%, respectively. It was significantly higher than the single detection index and the predictive value of sFlt-1/PLGF. Conclusions: 1. The serum corin,VEGF,PLGF,sFlt-1 levels of pregnant women in the early, middle and late stages of HDCP were significantly different from those of the control group, indicating that the above factors were related to the occurrence and development of HDCP. 2. The detection of serum corin,VEGF,PLGF,sFlt-1 levels in pregnant women at early and middle stages is of predictive value to the occurrence of HDCP, while the combined detection of serum corin,VEGF,PLGF, in pregnant women at early and middle stages of pregnancy is of great value. The level of sFlt-1 has higher sensitivity and specificity in predicting the occurrence of HDCP than the single factor detection. The results are more reliable and the prediction value is higher.
【学位授予单位】:兰州大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R714.246
【参考文献】
相关期刊论文 前10条
1 刘思华;张军;;胎盘生长因子在临床疾病相关作用的研究进展[J];心肺血管病杂志;2016年11期
2 韩瑾;张蒙;许遵鹏;潘敏;李东至;廖灿;;孕早期血清胎盘生长因子在妊娠期高血压疾病筛查中的应用[J];中国妇幼健康研究;2016年06期
3 高阳;周红辉;魏永琴;高志英;;胎盘生长因子水平与妊娠高血压疾病严重程度的关系[J];解放军医学院学报;2016年07期
4 邓莉;方碧梅;;妊娠期高血压疾病的临床流行病学分析[J];海南医学;2015年17期
5 程妤奋;黄鹰;杨慧琳;杨伶俐;邢秋霞;储莉鸣;沈丽华;张宝仁;古航;;PAPP-A、PLGF、sFlt-1预测妊娠期高血压疾病发病风险价值的研究[J];临床和实验医学杂志;2015年03期
6 郭芳芳;杨洁霞;;胎盘生长因子与妊娠关系的研究进展[J];中国妇幼保健;2014年36期
7 许香香;冯一奇;戴建荣;;胎盘蛋白13与胎盘生长因子联合检测对子痫前期患者的早期预测意义[J];中国计划生育和妇产科;2014年08期
8 罗晓帆;;孕早期外周血HIF-1α与VEGF水平对妊娠期高血压疾病的预测价值[J];河南预防医学杂志;2014年04期
9 王雪朋;;妊娠期高血压患者的C-反应蛋白与内皮素-1和NO水平的相关性研究[J];中国煤炭工业医学杂志;2014年06期
10 叶少珍;魏伟锋;吴成勇;;妊娠期高血压疾病患者血液指标变化的临床指导价值[J];中外医学研究;2014年15期
相关硕士学位论文 前1条
1 张s,
本文编号:2468358
本文链接:https://www.wllwen.com/yixuelunwen/fuchankeerkelunwen/2468358.html